HFMA Australia

hfma.org.au

At HFMA we strive to create a sustainable healthcare for a healthy Australia. Our mission is to connect and build capacity and capability in Australian health finance professionals in order for them to become leaders in the Health Industry. Our Strategic Plan will see many progressions into the future, as we take on new events and projects to allow our member benefits to grow.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HEALTHCARE ANALYTICS

HEARTBEAM ENTERS INTO STRATEGIC ALLIANCE AGREEMENT WITH SAMSUNG

Businesswire | May 31, 2023

news image

HeartBeam, Inc. a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. HeartBeam acquired the assets of LIVMOR earlier this year. Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, ta...

Read More

CERNER, INTERMOUNTAIN EXTEND TECHNOLOGY PARTNERSHIP

Healthcare IT News | February 18, 2020

news image

Cerner and its longtime client Intermountain Healthcare have announced a multiyear expansion of their technology partnership, and say they'll continue to innovate ways to boost quality, safety, and patient and provider experience. Intermountain has deployed an array of Cerner products across its two-dozen hospitals and 210 clinics to drive better outcomes and control costs. In a blog post, Cerner says the expansion will enable it to "continue to increase the speed of innovation and help...

Read More

FUTURE OF HEALTHCARE

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

news image

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More

HEALTH TECHNOLOGY

HEALTHPAY24® TO PARTNER WITH MATRIX IMAGING SOLUTIONS FOR BRINGING A COLLABORATIVE PATIENT EXPERIENCE

HealthPay24 | February 23, 2021

news image

To strengthen their process of patient engagement in the healthcare industry, HealthPay24 and Matrix Imaging Solutions are partnering. To offer customers a more cohesive and stronger experience for their patients, Matrix Imaging, a healthcare communications company, and HealthPay24, an all-in-one patient payment solution, will collaborate, Read More

news image

HEALTHCARE ANALYTICS

HEARTBEAM ENTERS INTO STRATEGIC ALLIANCE AGREEMENT WITH SAMSUNG

Businesswire | May 31, 2023

HeartBeam, Inc. a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung. HeartBeam acquired the assets of LIVMOR earlier this year. Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, ta...

Read More
news image

CERNER, INTERMOUNTAIN EXTEND TECHNOLOGY PARTNERSHIP

Healthcare IT News | February 18, 2020

Cerner and its longtime client Intermountain Healthcare have announced a multiyear expansion of their technology partnership, and say they'll continue to innovate ways to boost quality, safety, and patient and provider experience. Intermountain has deployed an array of Cerner products across its two-dozen hospitals and 210 clinics to drive better outcomes and control costs. In a blog post, Cerner says the expansion will enable it to "continue to increase the speed of innovation and help...

Read More
news image

FUTURE OF HEALTHCARE

MEDICAGO ANNOUNCES PUBLICATION OF PHASE 3 COVID-19 VACCINE STUDY RESULTS IN NEW ENGLAND JOURNAL OF MEDICINE

Medicago | May 06, 2022

Medicago announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine recombinant, adjuvanted, in the New England Journal of Medicine. The Phase 3 trial studied the two-dose regimen of COVIFENZ® given 21 days apart versus placebo in over 24,000 subjects aged 18 and above. Common side effects in the vaccine group included injection site pain, headache, fatigue, fever, muscle aches, and chills. COVIFENZ® is indicated for active immunizatio...

Read More
news image

HEALTH TECHNOLOGY

HEALTHPAY24® TO PARTNER WITH MATRIX IMAGING SOLUTIONS FOR BRINGING A COLLABORATIVE PATIENT EXPERIENCE

HealthPay24 | February 23, 2021

To strengthen their process of patient engagement in the healthcare industry, HealthPay24 and Matrix Imaging Solutions are partnering. To offer customers a more cohesive and stronger experience for their patients, Matrix Imaging, a healthcare communications company, and HealthPay24, an all-in-one patient payment solution, will collaborate, Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us